A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small study with 10 participants, researchers report that semaglutides, which are sold under brand names such as Ozempic and Wegovy, shows promise as a treatment for type 1 diabetes that ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three ...

GLP-1 drugs are not currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 1 diabetes — and they may never be.

RELATED: Ozempic side effects: Dangers of using diabetes drug for weight loss. Type 1 diabetes, which affects far fewer people, is a chronic disease where the body's own immune system typically ...

Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin. Treating ...

FDA Approves Fiasp for Patients with Type 1, Type 2 Diabetes Ozempic is available as 0.5mg and 1mg strength injections in single-patient-use pens that deliver 0.25mg, 0.5mg, or 1mg per injection.

Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Top News U.S. News ...